Singapore: Eisai has expressed strong disappointment with Institute for Quality and Efficiency in Health Care (IQWiG), G...
Singapore: Japanese firm Ono Pharmaceutical and BioFocus, a service division of Galapagos and based in the UK, have sign...
Singapore: Sosei has successfully completed a Japanese phase I trial for SO-1105 for the treatment of oropharyngeal cand...
Singapore: Updated results from a phase II study of orteronel, a selective oral 17,20 lyase inhibitor, dosed without pre...
Singapore: Takeda Pharmaceutical and Pfizer Japan have concluded an agreement that, as of December 31, 2012, Takeda will...
Singapore: The GBI Research has revealed that the non-small cell lung cancer (NSCLC) therapeutics market value in the As...
Singapore: Daiichi Sankyo has been approved for the Japanese Ministry of Economy, Trade and Industry's production facili...
Singapore: Kyowa Hakko Kirin has agreed to return development and marketing rights of Busulfex, for use as a part of con...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Leading biopharmaceutical company Aegerion Pharmaceuticals that is dedicated to the development and commercia...
Not long ago, it was one of India's iconic companies. Ranbaxy, which is now a subsidiary of Japanese giant Daiichi Sanky...
Singapore: Korea-based Celltrion has completed filing procedure of biosimilar drug Remsima to obtain Japan's Ministry of...
Singapore: Japanese pharmaceutical major Takeda has been ordered by a US Federal court to pay $6 billion in punitive dam...
Singapore: Cellectricon has expanded its sales and service network into Asia through a distribution agreement for its D...
Singapore: Japanese drug major Mitsubishi Tanabe Pharma has announced that one of its subsidiaries, Tianjin Tanabe Seiya...
Singapore: Scientists at Kyoto University, Japan, have discovered the 'reset button' in the brain, which could be used t...
Singapore: Takeda Global Research & Development Center resubmitted New Drug Applications (NDAs) to the US FDA for al...
Singapore: St Jude Medical, a global medical device company, launched Ilumien Optis System, a next-generation technology...
